Autopsy report · NCT03068975
Alvimopan Use in Polytraumatized Patients
Cause of deathSlow enrollment
“This study was terminated due to failure to enroll, a low volume of patients met criteria.”
Life of this trial
- Registered 6 months before it started.
- Ran for about 2 years 3 months before it stopped.
- 3 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 4
- Sponsor
- University of Puerto Rico
- Sponsor type
- University, hospital or other
- Conditions
- Post Operative Ileus
- Interventions
- Alvimopan; Placebo
- Participants
- 3
- Sites
- 1
- Countries
- Puerto Rico
Trials that died the same way
- Phase 2 Study of OBP-301 (Telomelysin™) in Combination With Pembrolizumab and SBRT in Patients With HNSCC With Inoperable, Recurrent or Progressive Disease
“This study was terminated due to low participant enrollment.” - The Effect on Mucosal Healing With Pentasa Sachet in Mild to Moderate Active "Drug: Crohn's Disease"
“Study terminated due to lack of eligible patients” - Assessment of the Effect of Tegaserod (2 mg Tid and 6 mg Tid) on Dyspeptic Symptoms in Diabetic Patients With Symptoms of Diabetic Gastropathy
“This study was terminated early in April 2005 due to low patient enrollment” - A Study of Duvelisib in Combination With Pembrolizumab in Head and Neck Cancer
“The study was terminated due to low enrollment.” - Aspirin as a Novel Anti-Inflammatory Modality in the Fontan Patients
“This study was terminated due to inability to recruit sufficient patients.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.